UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 33

Sortiert nach

Prognostic Value of Changes in N-Terminal Pro-Brain Natriuretic Peptide in Val-HeFT (Valsartan Heart Failure Trial)

Journal of the American College of Cardiology, 2008-09, Vol.52 (12), p.997-1003

2008

Link zum Volltext

Verfügbarkeit prüfen

Slowing the Progression of Cardiovascular Disease

Journal of the American College of Cardiology, 2016-04, Vol.67 (14), p.1698-1700

Cohn, Jay N., MD

2016

Link zum Volltext

Verfügbarkeit prüfen

Prevention of cardiovascular disease

Trends in cardiovascular medicine, 2015-07, Vol.25 (5), p.436-442

Cohn, Jay N., MD

2015

Link zum Volltext

Verfügbarkeit prüfen

Trials and Tribulations

Journal of cardiac failure, 2016-03, Vol.22 (3), p.180-181

Cohn, Jay N., MD

2016

Link zum Volltext

Verfügbarkeit prüfen

Elevated Plasma Renin Activity Predicts Adverse Outcome in Chronic Heart Failure, Independently of Pharmacologic Therapy: Data From the Valsartan Heart Failure Trial (Val-HeFT)

Journal of cardiac failure, 2010-12, Vol.16 (12), p.964-970

2010

Link zum Volltext

Verfügbarkeit prüfen

Underuse of cardiovascular preventive pharmacotherapy in patients presenting with ST-elevation myocardial infarction

The American heart journal, 2012-08, Vol.164 (2), p.259-267

2012

Link zum Volltext

Verfügbarkeit prüfen

Identifying the Risk and Preventing the Consequences of Cardiovascular Disease

Heart, lung & circulation, 2013-07, Vol.22 (7), p.512-516

Cohn, Jay N., MD

2013

Link zum Volltext

Verfügbarkeit prüfen

Endothelial Nitric Oxide Synthase (NOS3) Polymorphisms in African Americans With Heart Failure: Results From the A-HeFT Trial

Journal of cardiac failure, 2009-04, Vol.15 (3), p.191-198

2009

Link zum Volltext

Verfügbarkeit prüfen

Preventing Heart Failure: A Critique of Strategies

Journal of cardiac failure, 2013-04, Vol.19 (4), p.211-213

Cohn, Jay N., MD

2013

Link zum Volltext

Verfügbarkeit prüfen

What’s in a Name?

Journal of cardiac failure, 2012, Vol.18 (3), p.175-175

Cohn, Jay N., MD

2012

Link zum Volltext

Verfügbarkeit prüfen

Reply

Journal of cardiac failure, 2012, Vol.18 (6), p.513-513

Cohn, Jay N., MD

2012

Link zum Volltext

Verfügbarkeit prüfen

Influence of Blood Pressure on the Effectiveness of a Fixed-Dose Combination of Isosorbide Dinitrate and Hydralazine in the African-American Heart Failure Trial

Journal of the American College of Cardiology, 2007-01, Vol.49 (1), p.32-39

2007

Link zum Volltext

Verfügbarkeit prüfen

Clinical, Neurohormonal, and Inflammatory Markers and Overall Prognostic Role of Chronic Obstructive Pulmonary Disease in Patients With Heart Failure: Data From the Val-HeFT Heart Failure Trial

Journal of cardiac failure, 2007-12, Vol.13 (10), p.797-804

2007

Link zum Volltext

Verfügbarkeit prüfen

G-Protein Beta-3 Subunit Genotype Predicts Enhanced Benefit of Fixed-Dose Isosorbide Dinitrate and Hydralazine

JACC. Heart failure, 2014-12, Vol.2 (6), p.551-557

2014

Link zum Volltext

Verfügbarkeit prüfen

Detecting the Patient at Risk of Heart Failure

Journal of the American College of Cardiology, 2010-05, Vol.55 (19), p.2138-2139

Cohn, Jay N., MD

2010

Link zum Volltext

Verfügbarkeit prüfen

Isosorbide Dinitrate and Hydralazine in a Fixed-Dose Combination Produces Further Regression of Left Ventricular Remodeling in a Well-Treated Black Population With Heart Failure: Results From A-HeFT

Journal of cardiac failure, 2007-06, Vol.13 (5), p.331-339

2007

Link zum Volltext

Verfügbarkeit prüfen

Effect of Fixed-Dose Combined Isosorbide Dinitrate/Hydralazine in Elderly Patients in the African-American Heart Failure Trial

Journal of cardiac failure, 2012-08, Vol.18 (8), p.600-606

2012

Link zum Volltext

Verfügbarkeit prüfen

Relationship of Quality of Life Scores With Baseline Characteristics and Outcomes in the African-American Heart Failure Trial

Journal of cardiac failure, 2009-12, Vol.15 (10), p.835-842

2009

Link zum Volltext

Verfügbarkeit prüfen

Myocardial Structural Effects of Aldosterone Receptor Antagonism in Heart Failure

Journal of the American College of Cardiology, 2007-08, Vol.50 (7), p.597-599

Cohn, Jay N., MD, FACC

2007

Link zum Volltext

Verfügbarkeit prüfen

Atrial fibrillation and mortality in African American patients with heart failure: Results from the African American Heart Failure Trial (A-HeFT)

The American heart journal, 2011-07, Vol.162 (1), p.154-159

2011

Link zum Volltext

Verfügbarkeit prüfen

Vascular and cardiac functional and structural screening to identify risk of future morbid events: preliminary observations

Journal of the American Society of Hypertension, 2011-09, Vol.5 (5), p.401-409

2011

Link zum Volltext

Verfügbarkeit prüfen

Conflicts of Interest: To Eliminate Them or Manage Them

Journal of cardiac failure, 2009-06, Vol.15 (5), p.375-376

Cohn, Jay N., MD

2009

Link zum Volltext

Verfügbarkeit prüfen

Efficacy and Safety in Clinical Trials

Journal of the American College of Cardiology, 2007-02, Vol.49 (6), p.729-729

Cohn, Jay N., MD

2007

Link zum Volltext

Verfügbarkeit prüfen

Exploring the Potential Synergistic Action of Spironolactone on Nitric Oxide–Enhancing Therapy: Insights From the African-American Heart Failure Trial

Journal of cardiac failure, 2008-11, Vol.14 (9), p.718-723

2008

Link zum Volltext

Verfügbarkeit prüfen

Stage B, A Precursor of Heart Failure, Part II

Heart failure clinics, 2012-04, Vol.8 (2), p.xv-xv

2012

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 33

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(33)
Mit Volltextzugriff
(27)

Publikationsform

Artikel
(33)

Sprache

Englisch
(33)
Japanisch
(3)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Kollektion

Ingenta
(32)
Elsevier ScienceDirect Journals Complete
(32)
IngentaConnect Journals
(31)
MEDLINE
(24)
Elsevier Journal Backfiles on ScienceDirect (DFG Nationallizenzen)
(17)
EZB Electronic Journals Library
(8)
Journals@Ovid Ovid Full Text
(3)
Wiley-Blackwell Journals
(1)

3 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Prognostic Value of Changes in N-Terminal Pro-Brain Natriuretic Peptide in Val-HeFT (Valsartan Heart Failure Trial)

Slowing the Progression of Cardiovascular Disease

Prevention of cardiovascular disease

Trials and Tribulations

Elevated Plasma Renin Activity Predicts Adverse Outcome in Chronic Heart Failure, Independently of Pharmacologic Therapy: Data From the Valsartan Heart Failure Trial (Val-HeFT)

Underuse of cardiovascular preventive pharmacotherapy in patients presenting with ST-elevation myocardial infarction

Identifying the Risk and Preventing the Consequences of Cardiovascular Disease

Endothelial Nitric Oxide Synthase (NOS3) Polymorphisms in African Americans With Heart Failure: Results From the A-HeFT Trial

Preventing Heart Failure: A Critique of Strategies

What’s in a Name?

Reply

Influence of Blood Pressure on the Effectiveness of a Fixed-Dose Combination of Isosorbide Dinitrate and Hydralazine in the African-American Heart Failure Trial

Clinical, Neurohormonal, and Inflammatory Markers and Overall Prognostic Role of Chronic Obstructive Pulmonary Disease in Patients With Heart Failure: Data From the Val-HeFT Heart Failure Trial

G-Protein Beta-3 Subunit Genotype Predicts Enhanced Benefit of Fixed-Dose Isosorbide Dinitrate and Hydralazine

Detecting the Patient at Risk of Heart Failure

Isosorbide Dinitrate and Hydralazine in a Fixed-Dose Combination Produces Further Regression of Left Ventricular Remodeling in a Well-Treated Black Population With Heart Failure: Results From A-HeFT

Effect of Fixed-Dose Combined Isosorbide Dinitrate/Hydralazine in Elderly Patients in the African-American Heart Failure Trial

Relationship of Quality of Life Scores With Baseline Characteristics and Outcomes in the African-American Heart Failure Trial

Myocardial Structural Effects of Aldosterone Receptor Antagonism in Heart Failure

Atrial fibrillation and mortality in African American patients with heart failure: Results from the African American Heart Failure Trial (A-HeFT)

Vascular and cardiac functional and structural screening to identify risk of future morbid events: preliminary observations

Conflicts of Interest: To Eliminate Them or Manage Them

Efficacy and Safety in Clinical Trials

Exploring the Potential Synergistic Action of Spironolactone on Nitric Oxide–Enhancing Therapy: Insights From the African-American Heart Failure Trial

Stage B, A Precursor of Heart Failure, Part II

Suchergebnisse filtern